CGS-200-1 + CGS-200-5 + CGS-200 Vehicle
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Osteoarthritis, Knee
Conditions
Osteoarthritis, Knee, Pain
Trial Timeline
May 14, 2018 → Dec 30, 2018
NCT ID
NCT03528369About CGS-200-1 + CGS-200-5 + CGS-200 Vehicle
CGS-200-1 + CGS-200-5 + CGS-200 Vehicle is a phase 2 stage product being developed by Astellas Pharma for Osteoarthritis, Knee. The current trial status is completed. This product is registered under clinical trial identifier NCT03528369. Target conditions include Osteoarthritis, Knee, Pain.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03528369 | Phase 2 | Completed |
Competing Products
20 competing products in Osteoarthritis, Knee